The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
Open accessAbstract
Background: The political climate around Cannabis as a medicine is rapidly changing. Legislators are adopting policies regarding appropriate medical applications, while the paucity of research may make policy decisions around conditions for which Cannabis is an effective medicine difficult. Methods: An anonymous online survey was developed to query medical Cannabis users about the conditions they use Cannabis to treat, their use patterns, perception of efficacy, and physical and mental health. Participants were recruited through social media and Cannabis dispensaries in Washington State. Results: A total of 1429 participants identified as medical Cannabis users. The most frequently reported conditions for which they used Cannabis were pain (61.2%), anxiety (58.1%), depression (50.3%), headache/migraine (35.5%), nausea (27.4%), and muscle spasticity (18.4%). On average, participants reported an 86% reduction in symptoms as a result of Cannabis use; 59.8% of medical users reported using Cannabis as an alternative to pharmaceutical prescriptions. Global health scores were on par with the general population for mental health and physical health. Conclusions: While patient-reported outcomes favor strong efficacy for a broad range of symptoms, many medical users are using Cannabis without physician supervision and for conditions for which there is no formal research to support the use of Cannabis (e.g., depression and anxiety). Future research and public policy should attempt to reduce the incongruence between approved and actual use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
U.S. Department of Health and Human Services
(2006) · Encyclopedia of Sexual Behavior and the Law · doi:10.4135/9781452240107.n226 · Cited by 3,170
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Hays, R. D., Bjorner, J. B., Revicki, D. A., Spritzer, K. L., & Cella, D. (2009) · Quality of Life Research · doi:10.1007/s11136-009-9496-9 · Cited by 1,957
Opioid Epidemic in the United States
Manchikanti, L. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es9 · Cited by 1,180
Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771 · cited 1×
“CBD was isolated in 1940 from wild hemp (before THC in 1964) and preliminary results suggest it to be effective in relieving both anxiety and depression in animal models and in humans.(30,44,45) It is important to note that research has overwhelmingly represented the effects of THC, while whole plant studies taking th…”
BackgroundHistory of Cannabis and Its Preparations in Saga, Science, and Sobriquet
Russo, E. B. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790144 · Cited by 621
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Hidden formaldehyde in e-cigarette aerosols
Jensen, R. P., Luo, W., Pankow, J. F., Strongin, R. M., & Peyton, D. H. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1413069 · Cited by 605
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
Cannabinoids in medicine: A review of their therapeutic potential
Ben Amar, M. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.02.001 · Cited by 543
Crippa, J. A. S., Derenusson, G. N., Ferrari, T. B., Wichert-Ana, L., Duran, F. L., Martin-Santos, R., Simões, M. V., Bhattacharyya, S., Fusar-Poli, P., Atakan, Z., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379283 · Cited by 535
Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Englund, A., Morrison, P. D., Nottage, J., Hague, D., Kane, F., Bonaccorso, S., Stone, J. M., Reichenberg, A., Brenneisen, R., Holt, D., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112460109 · Cited by 462
Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization.
Small, E. (2015) · The Botanical Review · doi:10.1007/s12229-015-9157-3 · Cited by 461
Wade, D. T., Robson, P., House, H., Makela, P., & Aram, J. (2003) · Clinical Rehabilitation · doi:10.1191/0269215503cr581oa · Cited by 441
Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials
Lynch, M. E., & Campbell, F. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03970.x · Cited by 397
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use
Walsh, Z., Callaway, R., Belle-Isle, L., Capler, R., Kay, R., Lucas, P., & Holtzman, S. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.08.010 · Cited by 347
Reinarman, C., Nunberg, H., Lanthier, F., & Heddleston, T. (2011) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2011.587700 · Cited by 290
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
Zajicek, J. P., Hobart, J. C., Slade, A., Barnes, D., Mattison, P. G., & on behalf of the MUSEC Research Group (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302468 · Cited by 278
Bhattacharyya, S., Fusar-Poli, P., Borgwardt, S., Martin-Santos, R., Nosarti, C., O’Carroll, C., Allen, P., Seal, M. L., Fletcher, P. C., Crippa, J. A., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.17 · Cited by 246
The medicinal use of cannabis in the UK: results of a nationwide survey
Ware, M. A., Adams, H., & Guy, G. W. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00271.x · Cited by 239
Hazekamp, A., Ware, M. A., Muller-Vahl, K. R., Abrams, D., & Grotenhermen, F. (2013) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.805976 · Cited by 238
Cannabis as a substitute for alcohol and other drugs
Reiman, A. (2009) · Harm Reduction Journal · doi:10.1186/1477-7517-6-35 · Cited by 235
Baron, E. P. (2015) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 206
THE RACE/ETHNICITY DISPARITY IN MISDEMEANOR MARIJUANA ARRESTS IN NEW YORK CITY*
GOLUB, A., JOHNSON, B. D., & DUNLAP, E. (2007) · Criminology & Public Policy · doi:10.1111/j.1745-9133.2007.00426.x · Cited by 206
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
Schier, A. R. D. M., Ribeiro, N. P. D. O., Silva, A. C. D. O. E., Hallak, J. E. C., Crippa, J. A. S., Nardi, A. E., & Zuardi, A. W. (2012) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462012000500008 · Cited by 187
Schier, A. R. D. M., Ribeiro, N. D. C. R., Coutinho, D. C. O., Machado, S. E. D. C., Arias-Carrión, Ó., Crippa, J. A. S., Zuardi, A. W., Nardi, A. E., & Silva, A. R. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140612114838 · Cited by 177
Gomes, F. V., Resstel, L. B. M., & Guimarães, F. S. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2036-z · Cited by 174
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol
Hartman, R. L., Brown, T. L., Milavetz, G., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.238287 · Cited by 145
Method for the Analysis of Cannabinoids and Terpenes in Cannabis
Giese, M. W., Lewis, M. A., Giese, L., et al. (2015) · Journal of AOAC International · doi:10.5740/jaoacint.15-116 · Cited by 144
The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD
Piomelli, D., & Russo, E. B. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.29003.ebr · Cited by 133
Racial differences in marijuana-users’ risk of arrest in the United States
Ramchand, R., Pacula, R. L., & Iguchi, M. Y. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.02.010 · Cited by 111
Are medical marijuana users different from recreational users? The view from primary care
Roy‐Byrne, P., Maynard, C. C., Bumgardner, K., Krupski, A., Dunn, C. W., West, I. I., Donovan, D. M., Atkins, D. C., & Ries, R. K. (2015) · American Journal on Addictions · doi:10.1111/ajad.12270 · Cited by 103
Lazáry, J., Eszlári, N., Juhász, G., & Bagdy, G. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.003 · Cited by 100
Chapter 5 The Endocannabinoid System as A Target for Novel Anxiolytic and Antidepressant Drugs
Gaetani, S., Dipasquale, P., Romano, A., Righetti, L., Cassano, T., Piomelli, D., & Cuomo, V. (2009) · International Review of Neurobiology · doi:10.1016/s0074-7742(09)85005-8 · Cited by 83
Eisenberg, E., Ogintz, M., & Almog, S. (2014) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2014.941130 · Cited by 82
Prevalence of medical marijuana use in C alifornia, 2012
Ryan‐Ibarra, S., Induni, M., & Ewing, D. (2014) · Drug and Alcohol Review · doi:10.1111/dar.12207 · Cited by 79
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder
Betthauser, K. D., Pilz, J., & Vollmer, L. E. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140523 · Cited by 78
Gray, J. M., Wilson, C. D., Lee, T. T.-Y., Pittman, Q. J., Deussing, J. M., Hillard, C. J., McEwen, B. S., Schulkin, J. A., Karatsoreos, I. N., Patel, S., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.01.004 · Cited by 76
Isolation of Cannabinol, Cannabidiol and Quebrachitol from Red Oil of Minnesota Wild Hemp
ADAMS, R. L. P., Pease, D. C., & Clark, J. H. (1940) · Journal of the American Chemical Society · doi:10.1021/ja01865a080 · Cited by 76
Medical Cannabis Patients: Patient Profiles and Health Care Utilization Patterns
Reiman, A. (2007) · Complementary health practice review · doi:10.1177/1533210107301834 · Cited by 74
Cannabis, motivation, and life satisfaction in an internet sample
Barnwell, S. S., Earleywine, M., & Wilcox, R. R. (2006) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-1-2 · Cited by 70
Therapeutic benefits of cannabis: a patient survey.
Webb, C. W., & Webb, S. M. (2014) · Europe PMC (PubMed Central) · Cited by 65
Aggarwal, S. K. (2013) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31824c5e4c · Cited by 62
Isolation of a Physiologically Active Tetrahydrocannabinol from Cannabis Sativa Resin
Wollner, H. J., Matchett, J. R., Levine, J., & Loewe, S. (1942) · Journal of the American Chemical Society · doi:10.1021/ja01253a008 · Cited by 61
Self-Medication of Somatic and Psychiatric Conditions Using Botanical Marijuana
Osborn, L. A., Lauritsen, K. J., Cross, N. A., Davis, A. K., Rosenberg, H., Bonadio, F. T., & Lang, B. (2015) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2015.1096433 · Cited by 51
Aggarwal, S. K., Carter, G. T., Sullivan, M. D., ZumBrunnen, C., Morrill, R. L., & Mayer, J. D. (2012) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909112454215 · Cited by 29
Gobira, P. H., Almeida‐Santos, A. F., Guimarães, F. S., Moreira, F. A., & de Aguiar, D. C. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.014 · Cited by 12
Cited by
Russell, C., Rueda, S., Room, R., Tyndall, M., & Fischer, B. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.11.008 · Cited by 298
Abrams, D. I. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.01.003 · Cited by 296
Brown, J., & Winterstein, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070989 · Cited by 295
A Cross-Sectional Study of Cannabidiol Users
Corroon, J., & Phillips, J. A. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0006 · Cited by 289
van de Donk, T., Niesters, M., Kowal, M. A., Olofsen, E., Dahan, A., & van Velzen, M. (2019) · Pain · doi:10.1097/j.pain.0000000000001464 · Cited by 284
Metadata
- Authors
- Sexton, M., Cuttler, C., Finnell, J. S., & Mischley, L. K.
- Venue
- Cannabis and Cannabinoid Research
- Publisher
- SAGE Publications
- Published
- 2016-12
- Volume
- 1
- Issue
- 1
- Pages
- 131-138
- ISSN
- 2378-8763 (ISSN-L)
- OpenAlex
- W2462520275
- Cited by
- 336
- References
- 50
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.